Fundamental Valuation Report Anworth Mortgage Asset(ANH:NYS) Real Estate:REIT-Diversified This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.20 (USD) 01/03/2019 Weighted Valuation$4.34 (USD) Overall RatingFairly valued to slightly Undervalued by 3.3% Valuation …

Anworth Mortgage Asset (ANH:NYS) Fundamental Valuation Report Read more »

Read More

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

Seadrill Partners (SDLP:NYS) and Global Ship Lease (GSL:NYS) Trading at Less than Cash Value Read more »

Read More

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

Shaw Communications (SJR.A:TSX) and Cobalt 27 Capital (KBLT:TSX) Are Undervalued Read more »

Read More

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

Trillium Therapeutics (TRIL:TSE) and Maxar Technologies (MAXR:TSE) Are Biggest Stock Decliners YTD on TSE Read more »

Read More

Fundamental Valuation Report ACCO Brands(ACCO:NYS) Industrials:Business Equipment This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$9.30 (USD) 28/02/2019 Weighted Valuation$11.30 (USD) Overall RatingUndervalued by 21.6% Valuation Models Analyst Consensus: $12.50 (USD) …

ACCO Brands (ACCO:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report AbbVie(ABBV:NYS) Healthcare:Drug Manufacturers-Major This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$79.24 (USD) 28/02/2019 Weighted Valuation$92.73 (USD) Overall RatingUndervalued by 17.0% Valuation Models Analyst Consensus: $92.73 (USD) (in …

AbbVie (ABBV:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Acorda Therapeutics(ACOR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.74 (USD) 28/02/2019 Weighted Valuation$21.10 (USD) Overall RatingUndervalued by 43.2% Valuation Models Analyst Consensus: $23.67 (USD) (in …

Acorda Therapeutics (ACOR:NAS) Fundamental Valuation Report Read more »

Read More